Gianfranco Caselli

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Venues

British journal of pharmacology

Toxicologic pathology

Arthritis research & therapy

RSC advances

Rottapharm Biotech Srl

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rottapharm Biotech Srl Apr 1o 2014

Italy

Direttore :: Farmacologia e Tossicoologia

Publications

Bibiana C Mota, Nathan Ashburner, Laura Abelleira-Hervas, Liyueyue Liu, Robertas Aleksynas, Lucio Claudio Rovati, Gianfranco Caselli, Magdalena Sastre
I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice. International journal of molecular sciences 23 (13) (2022)
Yuval Ramot, Gianfranco Caselli, Luigi Aurisicchio, Isabella Andreini, Emanuele Marra, Laura Luberto, Daniela Stoppoloni, Maria Lucrezia Pacello, Laura Monetini, Abraham Nyska
Toxicity and Local Tolerance of COVID- eVax, a Plasmid DNA Vaccine for SARS-CoV-2, Delivered by Electroporation. Toxicologic pathology 49 (7) (2021)
Emanuele Sala, Flora Ferrari, Marco Lanza, Chiara Milia, Chiara Sabatini, Albino Bonazzi, Eleonora Comi, Miriam Borsi Franchini, Gianfranco Caselli, Lucio Claudio Rovati
Improved efficacy, tolerance, safety, and abuse liability profile of the combination of CR4056 and morphine over morphine alone in rodent models. British journal of pharmacology 177 (14) (2020)
Vittorio Vellani, Chiara Sabatini, Chiara Milia, Gianfranco Caselli, Marco Lanza, Ornella Letari, Lucio Claudio Rovati, Chiara Giacomoni
CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons. British journal of pharmacology 177 (1) (2019)
Gianfranco Caselli, Albino Bonazzi, Marco Lanza, Flora Ferrari, Daniele Maggioni, Cristian Ferioli, Roberto Giambelli, Eleonora Comi, Silvia Zerbi, Marco Perrella, Ornella Letari, Elena Di Luccio, Milena Colovic, Stefano Persiani, Tiziano Zanelli, Laura Mennuni, Tiziana Piepoli, Lucio Claudio Rovati
Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug. Arthritis research & therapy 20 (1) (2018)
Vincenzo Razzano, Marco Paolino, Annalisa Reale, Germano Giuliani, Alessandro Donati, Gianluca Giorgi, Roberto Artusi, Gianfranco Caselli, Michela Visintin, Francesco Makovec, Salvatore Battiato, Filippo Samperi, Francesca Villafiorita-Monteleone, Chiara Botta, Andrea Cappelli
Poly-histidine grafting leading to fishbone-like architectures. RSC advances 8 (16) (2018)

Gianfranco Caselli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gianfranco Caselli